Yemaachi Biotechnology vs Alphabet Inc.

Side-by-side comparison of AI visibility scores, market position, and capabilities

Alphabet Inc. leads in AI visibility (91 vs 39)
Yemaachi Biotechnology logo

Yemaachi Biotechnology

EmergingHealthcare

General

Precision oncology biotech developing African population-specific cancer diagnostics; $25M Cancer Grand Challenges award with Roche partnership on The African Cancer Atlas in Ghana.

AI VisibilityBeta
Overall Score
D39
Category Rank
#538 of 1158
AI Consensus
76%
Trend
up
Per Platform
ChatGPT
41
Perplexity
41
Gemini
34

About

Yemaachi Biotechnology is a precision oncology company applying immunogenomics, bioinformatics, and AI to develop cancer diagnostics and treatments specifically calibrated for African and African-descent populations — addressing the critical gap in oncology research where most cancer data and therapies have been developed on predominantly European-ancestry patient populations, leaving African patients underserved by current diagnostic tools and treatment protocols. Founded and backed by Y Combinator, Yemaachi is based in Accra, Ghana and has raised $29+ million including a $25 million Cancer Grand Challenges award and a $3 million seed round led by V8 Capital.\n\nYemaachi's research platform combines the collection of cancer genomics data from African patients (building one of the largest African cancer biobanks) with AI analysis to identify genomic variants, immune signatures, and biomarkers specific to African populations. This enables the development of diagnostic tests calibrated for African-specific tumor biology and the identification of therapeutic targets that may differ from European-ancestry cancer drivers. The company launched the Sheba HPV Test in Ghana (cervical cancer screening) and is partnering with Roche on The African Cancer Atlas — a comprehensive genomic characterization of cancer across Africa.\n\nIn 2025, Yemaachi operates at the intersection of oncology research, diagnostics, and population genomics for an underserved market. Cancer is a growing health crisis across sub-Saharan Africa, where late-stage diagnosis is the norm due to limited screening infrastructure and the poor sensitivity of Western-developed tests on African patients. Yemaachi's approach — building African-specific cancer intelligence — positions the company as both a research institution and a commercial diagnostics provider. The 2025 strategy focuses on expanding the African Cancer Atlas partnership with Roche, launching additional HPV and cancer screening products across West Africa, and partnering with global pharma companies seeking to include African populations in clinical trials.

Full profile
Alphabet Inc. logo

Alphabet Inc.

LeaderCommunications

General

Mountain View AI and digital advertising conglomerate (NASDAQ: GOOGL) $350B FY2024 revenue (+15%); Google Search 90%+ share, Google Cloud $43.2B (+30%), Gemini AI, DOJ monopoly ruling 2024.

AI VisibilityBeta
Overall Score
A91
Category Rank
#14 of 1158
AI Consensus
63%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
99
Gemini
86

About

Alphabet Inc. is a Mountain View, California-based technology conglomerate — publicly traded on the NASDAQ (NASDAQ: GOOGL, GOOG) as an S&P 500 Information Technology component — operating as the holding company for Google (Search, YouTube, Google Ads, Gmail, Google Cloud, Android, Chrome, Maps, Play Store, Workspace), and Other Bets (Waymo autonomous vehicles, DeepMind AI research, Verily life sciences, Wing drone delivery, Google Fiber) through approximately 183,000 full-time employees. In fiscal year 2024, Alphabet reported revenues of $350 billion (+15% year-over-year), with Google Services (Search, YouTube, Google Play, subscriptions) generating $307 billion, Google Cloud generating $43.2 billion (+30%), and Other Bets $2.0 billion, while generating $100 billion in net income — reflecting Alphabet's position as one of the highest-profit companies in history, funded by Google Search's advertising monopoly (processing 8.5+ billion searches daily, commanding 90%+ global search market share). CEO Sundar Pichai has prioritized Alphabet's AI-first transformation: the 2024 launch of Gemini Ultra 1.0, Gemini 1.5 Pro (1 million token context window — largest at launch), and Gemini 2.0 Flash positioned Google as a competitive AI frontier model lab alongside OpenAI, following the ChatGPT disruption that temporarily threatened Google's search advertising dominance in 2023. Google Cloud's Vertex AI platform (enterprise AI model deployment with Gemini, Llama, and third-party models) and Google Distributed Cloud (air-gapped government cloud) compete directly with Microsoft Azure AI and AWS SageMaker for enterprise AI workload contracts. Waymo's commercial robotaxi operations in San Francisco, Phoenix, and Los Angeles (Waymo One — fully driverless rides, generating revenue and operational data) represent Alphabet's highest-upside long-duration investment.

Full profile

AI Visibility Head-to-Head

39
Overall Score
91
#538
Category Rank
#14
76
AI Consensus
63
up
Trend
stable
41
ChatGPT
88
41
Perplexity
99
34
Gemini
86
40
Claude
95
33
Grok
99

Key Details

Category
General
General
Tier
Emerging
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.